Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB3P5 is a human pseudogene that lacks the capability to encode a functional NADH:ubiquinone oxidoreductase subunit B3 protein and typically contains mutations or sequence defects that preclude the synthesis of the active protein[1][4][5]. It is labeled as a processed or non-functional copy of the NDUFB3 gene, which in its functional form is a subunit of mitochondrial respiratory chain complex I. Pseudogenes are generally transcriptionally silent but may rarely be transcribed; their RNA may have regulatory effects on gene expression by serving as decoys for microRNAs or affecting stability of related mRNAs in very specific contexts (no evidence for this pseudogene)[5]. NDUFB3P5 is not a receptor, enzyme, transporter, or transcription factor; it is not relevant as a drug target or biomarker and has no reported disease involvement[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B3 pseudogene 5 (NDUFB3P5).